MAR-DULOXETINE

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: 2619c5f5ccfe3732
Drug Approval Canada Name: MAR-DULOXETINE
Product Name: MAR-DULOXETINE
Status: Marketed
Status Date: 2019-05-14
Original Market Date: 2016-05-10
Din: 02446103
Drug Class: Human
Dosage Form: Capsule (Delayed Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.16
Atc Original: N06AX21 DULOXETINE
Atc Name: n 06 ax 21
Aig Number: 0152350002
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

DULOXETINE (DULOXETINE HYDROCHLORIDE)

60 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2619c5f5ccfe3732

Type

Standard